Quick Answer
Orthofix Medical Inc. reported Operating Income Loss of -$81.43 million for the year ending 2025.
- Orthofix Medical Inc. showed an increase of +3.8% in Operating Income Loss from 2024 to 2025.
- This data is from Orthofix Medical Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: -$10.08 million | Q1 2014: -$29.0 thousand | Q2 2014: $6.70 million | Q3 2014: $6.51 million | Q4 2014: $3.95 million | Q1 2015: -$7.19 million | Q2 2015: $4.93 million | Q3 2015: $4.14 million | Q4 2015: $7.38 million | Q1 2016: $7.08 million | Q2 2016: -$2.70 million | Q3 2016: $9.27 million | Q4 2016: $7.42 million | Q1 2017: $5.92 million | Q2 2017: $8.00 million | Q3 2017: $9.03 million | Q4 2017: $17.86 million | Q1 2018: $7.87 million | Q2 2018: $5.92 million | Q3 2018: $3.91 million | Q4 2018: $12.40 million | Q1 2019: -$4.45 million | Q2 2019: $451.0 thousand | Q3 2019: -$18.88 million | Q4 2019: $4.10 million | Q1 2020: $6.85 million | Q2 2020: -$21.00 million | Q3 2020: $4.18 million | Q1 2021: -$2.92 million | Q2 2021: $4.27 million | Q3 2021: -$313.0 thousand | Q1 2022: -$3.08 million | Q2 2022: $6.64 million | Q3 2022: -$5.79 million | Q1 2023: -$59.71 million | Q2 2023: -$36.63 million | Q3 2023: -$24.45 million | Q1 2024: -$29.34 million | Q2 2024: -$24.91 million | Q3 2024: -$18.90 million | Q1 2025: -$48.87 million | Q2 2025: -$16.00 million | Q3 2025: -$17.05 million.
- Over the full 17 years of available data (2009 to 2025), Orthofix Medical Inc.'s Operating Income Loss has declined by 227.5%.
- Historical annual values: Fiscal year 2025: -$81.43 million | Fiscal year 2024: -$84.62 million | Fiscal year 2023: -$139.11 million | Fiscal year 2022: -$13.27 million | Fiscal year 2021: -$8.32 million | Fiscal year 2020: -$6.27 million | Fiscal year 2019: -$18.78 million | Fiscal year 2018: $30.09 million | Fiscal year 2017: $40.81 million | Fiscal year 2016: $21.07 million | Fiscal year 2015: $9.26 million | Fiscal year 2014: $17.14 million | Fiscal year 2013: -$11.19 million | Fiscal year 2012: $74.87 million | Fiscal year 2011: $5.90 million | Fiscal year 2010: $66.25 million | Fiscal year 2009: $63.88 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: